The emerging treatment of tirzepatide peptide represents a significant development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment